Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:12 PM
Ignite Modification Date:
2025-12-24 @ 2:12 PM
NCT ID:
NCT02468895
Eligibility Criteria:
Gender Both female and males
Age limits Patients \>/= 18 years
Accept healthy volunteers No
Eligibility criteria
Inclusion Criteria:
* Polymyositis
* Dermatomyositis (including amyopathic)
* Inclusion body myositis
* Anti-synthetase syndrome
* Myositis overlapping with another connective tissue disorder
* Cancer-associated myositis
* Immune-mediated necrotising myopathy including statin-induced myositis
* Juvenile myositis persisting into adulthood
* Fasciitis including eosinophilic myofasciitis
* Vasculitis affecting muscle
* Granulomatous myositis
* Focal myositis
* Orbital myositis
* Suspected myositis under investigation
* CTD features in association with a myositis specific / associated antibody
Exclusion Criteria:
* Patients with disease duration \>2 years
* Patients \< 18 years
* Confirmed non-inflammatory myopathies
* Myositis secondary to alcohol or drug abuse
* Patients unwilling or unable to give consent
* Patients with poor or no venous access
* Patients where MR imaging is contraindicated (for MR substudy)
Study population description Patients referred to tertiary level UK myositis clinics
Sampling methods N/A, this is a prospective study of consecutive eligible patients
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT02468895
Study Brief:
Protocol Section:
NCT02468895